Gordian Capital (Singapore)’s ARK Genomic Revolution ETF ARKG Stock Holding History

Gordian Capital (Singapore)’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-250	Closed	-$5.87K	–	191
2024 Q2	$5.87K	Hold	250	–	–	﹤0.01%	113
2024 Q1	$7.19K	Hold	250	–	–	0.01%	67
2023 Q4	$8.2K	Hold	250	–	–	0.01%	56
2023 Q3	$6.96K	Hold	250	–	–	0.01%	54
2023 Q2	$8.52K	Hold	250	–	–	0.01%	51
2023 Q1	$8K	Hold	250	–	–	0.01%	54
2022 Q4	$8K	Sell	250 -300	-55%	-$9.52K	0.01%	54
2022 Q3	$21K	Hold	550	–	–	0.03%	53
2022 Q2	$17K	Sell	550 -1,550	-74%	-$54.2K	0.02%	75
2022 Q1	$104K	Hold	2,100	–	–	0.08%	60
2021 Q4	$129K	Buy	+2,100	New	+$145K	0.1%	70

Other funds holding ARKG

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Gordian Capital (Singapore)'s ARKG Position: Q3 2024 in Review

Gordian Capital (Singapore) sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2024, closing a stake of 250 shares — an estimated $5.87K sold.

Gordian Capital (Singapore) first reported a position in ARKG in Q4 2021 and held it in 11 quarters. The position peaked at $129K in Q4 2021. 239 funds tracked by Wall St. Rank hold ARKG as of Q3 2024.

Gordian Capital (Singapore) reported no remaining ARK Genomic Revolution ETF position as of Q3 2024 after selling out during the quarter.
Gordian Capital (Singapore) sold 250 ARK Genomic Revolution ETF shares in Q3 2024, an estimated $5.87K.
Gordian Capital (Singapore) first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 11 quarters.
Gordian Capital (Singapore)'s ARK Genomic Revolution ETF position peaked at $129K in Q4 2021.
239 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2024.

Based on Gordian Capital (Singapore)'s 13F filing for Q3 2024, filed 15 Nov 2024.